Dobutamin Hameln 12,5 mg/ml koncentrat za otopinu za infuziju
| Name | Dobutamin Hameln 12,5 mg/ml koncentrat za otopinu za infuziju |
|---|---|
| Former Name | Dobutamin Pharma Roth 12,5 mg/ml koncentrat za otopinu za infuziju |
| Marketing Authorisation Number | HR-H-557458919 |
| Active Substance | dobutaminklorid |
| Composition | 1 ml koncentrata za otopinu za infuziju sadrži 12,5 mg dobutamina |
| Pharmaceutical Form | koncentrat za otopinu za infuziju |
| Manufacturer | Siegfried Hameln GmbH, Hameln, Njemačka hameln rds s.r.o., Modra, Slovačka |
| Marketing Authorisation Holder | hameln pharma gmbh, Inselstrasse 1, Hameln, Njemačka |
| Marketing Authorisation Date | 12.01.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/20-02/148 |
| Registration Number | 381-12-01/30-21-02 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C01CA07 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
